Table 4.
Atrial fibrillation treatment | n (%) (n = 301) |
---|---|
Patients with at least one AAD | 249 (82.7) |
Class IC (Flecainide, other) | 4 (1.3) |
Class II, beta-blockers | 116 (38.5) |
Class III | 118 (39.2) |
Amiodarone | 112 (37.2) |
Sotalol | 6 (2.0) |
Others | 4 (1.3) |
Class IV, calcium-channel blockers | 75 (24.9) |
Cardiac glycosides | 96 (31.9) |
AAD, antiarrhythmic drug.